Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Assets (2016 - 2025)

Historic Return on Assets for Gyre Therapeutics (GYRE) over the last 17 years, with Q3 2025 value amounting to 0.07%.

  • Gyre Therapeutics' Return on Assets rose 7600.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 0.14% for FY2024, which is 10000.0% up from last year.
  • Gyre Therapeutics' Return on Assets amounted to 0.07% in Q3 2025, which was up 7600.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Return on Assets registered a high of 0.43% during Q1 2023, and its lowest value of 1.67% during Q1 2022.
  • For the 5-year period, Gyre Therapeutics' Return on Assets averaged around 0.56%, with its median value being 0.68% (2024).
  • The largest annual percentage gain for Gyre Therapeutics' Return on Assets in the last 5 years was 21000bps (2023), contrasted with its biggest fall of -15100bps (2023).
  • Quarter analysis of 5 years shows Gyre Therapeutics' Return on Assets stood at 1.31% in 2021, then skyrocketed by 105bps to 0.06% in 2022, then plummeted by -2407bps to 1.36% in 2023, then skyrocketed by 110bps to 0.13% in 2024, then plummeted by -49bps to 0.07% in 2025.
  • Its Return on Assets was 0.07% in Q3 2025, compared to 0.05% in Q2 2025 and 0.08% in Q1 2025.